Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-043337
Filing Date
2013-08-07
Accepted
2013-08-07 16:30:30
Documents
1
Period of Report
2013-08-05

Document Format Files

Seq Description Document Type Size
1 RULE 10B5-1 PLAN TRANSACTION rrd387477.html 4  
1 RULE 10B5-1 PLAN TRANSACTION rrd387477.xml 4 7669
  Complete submission text file 0001181431-13-043337.txt   9259
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INCYTE CORPORATION 3160 PORTER DRIVE PALO ALTO CA 93404
Business Address
WHITFIELD ROY A (Reporting) CIK: 0000936728 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 131018023